HBIO Files 8-K: Q2 Press Release Furnished, Call Scheduled
Rhea-AI Filing Summary
Harvard Bioscience, Inc. announced a press release with financial results for the three and six months ended June 30, 2025, and scheduled a conference call at 8:00 AM ET on August 11, 2025. The Current Report (Form 8-K) states the press release is furnished as Exhibit 99.1 and that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference except by specific reference in a future filing.
The report lists Exhibit 99.1 (press release) and Exhibit 104 (cover page interactive data) and is signed by Mark Frost, Interim Chief Financial Officer. No financial figures or performance metrics are provided within this 8-K; readers must consult Exhibit 99.1 for substantive results.
Positive
- Company notified investors publicly of Q2 and six-month results and scheduled an investor conference call
- Press release furnished as Exhibit 99.1 with interactive data included as Exhibit 104
Negative
- No financial figures or performance metrics are included within this 8-K; substantive results are not present in the filing
- Disclosure is "furnished" and not "filed," limiting Section 18 liability and incorporation by reference, which reduces legal recourse tied to the 8-K itself
Insights
TL;DR: The company announced Q2/QTD results and an investor call, but the 8-K furnishes the press release without including financial figures.
The Form 8-K communicates that Harvard Bioscience issued a press release covering results for the three and six months ended June 30, 2025, and scheduled a conference call at 8:00 AM ET on August 11, 2025. Because the numbers are not included in this filing, the immediate material impact of this 8-K is limited; investors must review Exhibit 99.1 and attend or listen to the conference call to assess performance. The filing follows common disclosure practice of furnishing press releases and interactive data.
TL;DR: The 8-K furnishes a press release and clarifies legal status of the disclosure; signature by an interim CFO is noted.
The report explicitly states the press release is "furnished" rather than "filed," which limits Section 18 liability and prevents automatic incorporation by reference into future filings absent specific reference. The filing also identifies Mark Frost as Interim Chief Financial Officer signing the report. For governance and disclosure oversight, stakeholders should note the distinction between furnished and filed materials and refer to Exhibit 99.1 for the substantive information underlying this disclosure.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
_______________________________
(Exact name of registrant as specified in its charter)
______________________________
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
(Address of Principal Executive Offices) (Zip Code)
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
____________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Securities registered pursuant to Section 12(b) of the Act: |
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On August 11, 2025, Harvard Bioscience, Inc. (the “Company”) issued a press release announcing financial results for the three and six months ended June 30, 2025, and the details of a related conference call to be held at 8:00 AM ET on August 11, 2025. The press release is furnished as Exhibit 99.1 and incorporated herein by reference.
The information in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit Number | Description | |
| 99.1 | Press Release issued by Harvard Bioscience, Inc. on August 11, 2025 | |
| 104 | Cover Page Interactive Data File (embedded within the XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| HARVARD BIOSCIENCE, INC. | |||
| Date: August 11, 2025 | By: | /s/ Mark Frost | |
| Mark Frost | |||
| Interim Chief Financial Officer | |||
FAQ
When did Harvard Bioscience (HBIO) announce results for Q2 2025?
Which periods are covered by the announced results?
When is the investor conference call scheduled?
Where can I find the full press release referenced in the 8-K?
Is the information in the press release considered "filed" with the SEC?
